The American Society of Gene and Cell Therapy (ASGCT) debuted an initiative addressing the market failure in rare disease gene and cell therapies.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
ASGCT Debuts Initiative to Correct 'Market Failure' in Rare Disease Gene Therapies | Precision Medicine Online
300+ millions Rare disease patients
95% % Rare diseases
Lack Commercial Viability Gene therapies